Searched for
FINANCIAL GROWTH IN DIAGNOSTICS
Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broadly in line with industry ben...- Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?Molbio Diagnostics aims to secure ₹200 crore to enhance its capital expenditures through a new issuance of shares. In tandem, the firm inte...
- World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor roundMolbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 cr...
- For medium- to long-term investors seeking sustainable growth: 5 large- and mid-caps with upside potential of up to 28%When a market starts to recover, as it is these days, the temptation is to chase whatever is running the fastest (essentially momentum). Bu...
- KKR deepens India healthcare bet with $1.39 billion Medicover acquisitionGlobal investment firm KKR has acquired Medicover India's hospital network for $1.39 billion. This acquisition marks KKR's third hospital p...
- Quote of the day by Sylvester Stallone: "It ain't about how hard you hit. It's about..." — Inspiring life lessons on resilience, perseverance, mental toughness, courage, personal growth, success, and why embracing life's setbacks often becomes the real path to winning by the American actor, filmmaker, and creator of the iconic Rocky franchiseFamous quote of the day by Sylvester Stallone: Sylvester Stallone's famous quote, "It ain't about how hard you hit. It's about how hard you...
- How Rs. 40,000 Regular Income from Bonds Can Ease the Liquidity Pressure on the Sandwich GenerationMiddle-aged families face financial stress from competing responsibilities and unexpected expenses. A dedicated bond portfolio can provide ...
- Manipal Health shares slide 6% on account of profit booking. What should investors do?Manipal Health Enterprises shares fell sharply on Thursday day after their strong market debut, triggering profit booking. Analysts remain ...
- KKR buys Medicover’s India hospitals businessGlobal investment firm KKR has acquired Medicover India's hospital business. Sources said the the transaction values the hospital chain at ...
- Molbio Diagnostics IPO to open on August 10, price band set at Rs 768-807Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore public issue...
- Manipal Health shares list at 11% premium to beat GMP estimates. What should allotted investors do?Manipal Health Enterprises shares debuted at an 11% premium over the IPO price, beating grey market expectations. Brokerages remain constru...
- Manipal Health Enterprises shares list at 11% premium over IPO price on BSE, NSEManipal Health Enterprises shares debuted on Wednesday with an 11% premium. The IPO garnered strong demand, especially from institutional i...
- ET Family Business Awards' winners in the limelight: Apollo Hospitals and Muthoot FinCorpApollo Hospitals and Muthoot FinCorp received prestigious family business awards. Preetha Reddy highlighted Apollo's commitment to accessib...
- Cupid increases investment by $5 million in GII’s Healthcare-focused platformCupid Ltd has made an additional $5 million investment in GII’s healthcare-focused investment platform, funded through internal accruals. T...
- Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?Manipal Health Enterprises' large IPO is experiencing cautious investor interest on its second day. The grey market premium remains modest,...
- Smallcaps set for strong earnings rebound in FY27; Mirae Asset’s Varun Goel names 3 winning themesHe expects a robust recovery in FY27 and sees the strongest opportunities in capital goods, financials and healthcare, while remaining caut...
- Motilal Oswal raises mid and smallcap allocation to 50%, stays neutral on Indian equitiesMotilal Oswal Private Wealth favors Indian mid and small-cap stocks. They are increasing allocations to these segments by ten percentage po...
- Up to 12 pc of non-agri jobs at risk of substitution due to Gen AI: ReportIn a special report, Wall Street brokerage Goldman Sachs said the labour market impacts of gen-AI are expected to be "uneven" and it looks ...
- Gen-AI to boost India's labour productivity by 0.4 percentage points annually over next decade: Goldman SachsOver the next decade, generative AI is poised to significantly enhance India's labour productivity, particularly in knowledge-driven sector...
- Dr Lal PathLabs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?Dr Lal PathLabs shares surged after a strong Q1FY27 earnings beat, driven by higher realisations and price hikes. Brokerages including Nomu...
Load More
